EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Alternative splicing in EMT and TGF-β signaling during cancer progression

Ying E Zhang, Christina H Stuelten

Seminars in Cancer Biology · 2024-06 · 101 · 1-11

DOI: 10.1016/j.semcancer.2024.04.001 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Seminars in Cancer Biology, 2024-06. Verfasst von Ying E Zhang und 1 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Cellular and Molecular Biology, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA. Electronic address: zha…. Hauptthemen laut MEDLINE: Epithelial-Mesenchymal Transition, Alternative Splicing, Transforming Growth Factor beta, Neoplasms. Die Arbeit wurde bisher 96-mal zitiert (Crossref) und nennt 144 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Intramural NIH HHS, National Institutes of Health, Center for Cancer Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Epithelial to mesenchymal transition (EMT) is a physiological process during development where epithelial cells transform to acquire mesenchymal characteristics, which allows them to migrate and colonize secondary tissues. Many cellular signaling pathways and master transcriptional factors exert a myriad of controls to fine tune this vital process to meet various developmental and physiological needs. Adding to the complexity of this network are post-transcriptional and post-translational regulations. Among them, alternative splicing has been shown to play important roles to drive EMT-associated phenotypic changes, including actin cytoskeleton remodeling, cell-cell junction changes, cell motility and invasiveness. In advanced cancers, transforming growth factor-β (TGF-β) is a major inducer of EMT and is associated with tumor cell metastasis, cancer stem cell self-renewal, and drug resistance. This review aims to provide an overview of recent discoveries regarding alternative splicing events and the involvement of splicing factors in the EMT and TGF-β signaling. It will emphasize the importance of various splicing factors involved in EMT and explore their regulatory mechanisms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Epithelial-Mesenchymal TransitionAlternative SplicingTransforming Growth Factor betaNeoplasmsSignal TransductionHumansAnimalsDisease ProgressionGene Expression Regulation, Neoplastic

Stichwörter der Autor:innen

Alternative splicingEMTTGF-βsplicing factor

Substanzen

Transforming Growth Factor beta

Autor:innen und Institutionen

  • Laboratory of Cellular and Molecular Biology, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA. Electronic address: zhangyin@mail.nih.gov.
  • Laboratory of Cellular and Molecular Biology, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA.

Förderung

  • Intramural NIH HHS
  • National Institutes of Health
  • Center for Cancer Research
  • National Cancer Institute

Zitieren

APA

Zhang, Y. E., & Stuelten, C. H. (2024). Alternative splicing in EMT and TGF-β signaling during cancer progression. Seminars in Cancer Biology, 101, 1-11. https://doi.org/10.1016/j.semcancer.2024.04.001

Vancouver

Zhang YE, Stuelten CH. Alternative splicing in EMT and TGF-β signaling during cancer progression. Seminars in Cancer Biology. 2024;101:1-11. doi:10.1016/j.semcancer.2024.04.001

BibTeX
@article{Zhang2024,
  author = {Zhang, Ying E and Stuelten, Christina H},
  title = {Alternative splicing in EMT and TGF-β signaling during cancer progression},
  journal = {Seminars in Cancer Biology},
  year = {2024},
  volume = {101},
  pages = {1--11},
  doi = {10.1016/j.semcancer.2024.04.001}
}
Kostenlos starten →